Evidence map›Paper›PMID 28749326›Full record

ArticleMicrobiology (Reading, England)2017

Pneumococcal neuraminidase activates TGF-β signalling.

Nina Gratz, Lip Nam Loh, Beth Mann, Geli Gao, Robert Carter, Jason Rosch, Elaine I Tuomanen

Open access · hybridAbstract read
In one paragraph

Article in Microbiology (Reading, England), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Pore-forming activity ofInfection and immunity · 2023
    Article
  6. Inhibitors of the Sialidase NEU3 as Potential Therapeutics for Fibrosis.International journal of molecular sciences · 2022
    Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. The Role of TGF-Evidence-based complementary and alternative medicine : eCAM · 2021
    Review
  12. Inhibiting Sialidase-Induced TGF-The Journal of pharmacology and experimental therapeutics · 2021
    Article
  13. Attenuated pulmonary fibrosis in sialidase-3 knockout (American journal of physiology. Lung cellular and molecular physiology · 2020
    Article
  14. Review
  15. Review
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Nina GratzDepartments of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
Lip Nam LohDepartments of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
Beth MannDepartments of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
Geli GaoDepartments of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
Robert CarterComputational Biology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
Jason RoschDepartments of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
Elaine I TuomanenDepartments of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
St. Jude Children's Research Hospital · US

Funding

Viral Vector Technology (VVTSR)P30CA021765 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI CHARLES ROBERTS · 1985 to 2026
$166.9M
PNEUMOCOCCAL CELL WALL IN MENINGITISR01AI027913 · NIAID · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI TUOMANEN, ELAINE I · 1989 to 2015
$5.2M
NCI NIH HHS P30 CA021765NIAID NIH HHS R01 AI027913
6 · The paper itself

Abstract

Neuraminidase A (NanA) is an important virulence factor that is anchored to the pneumococcal cell wall and cleaves sialic acid on host substrates. We noted that a secreted allele of NanA was over-represented in invasive pneumococcal isolates and promoted the development of meningitis when swapped into the genome of non-meningitis isolates replacing cell wall-anchored NanA. Both forms of recombinant NanA directly activated transforming growth factor (TGF)-β, increased SMAD signalling and promoted loss of endothelial tight junction ZO-1. However, in assays using whole bacteria, only the cell-bound NanA decreased expression of ZO-1 and showed NanA dependence of bacterial invasion of endothelial cells. We conclude that NanA secretion versus retention on the cell surface does not influence neurotropism of clinical isolates. However, we describe a new NanA-TGF-β signalling axis that leads to decreased blood-brain barrier integrity and enhances bacterial invasion.

Indexed as

meningitisneuraminidasepneumococcusTGFβ

Identifiers

PMID28749326
PMCPMC5817201
OpenAlexW2740745854

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.